We are pleased to announce the Cold Spring Harbor Asia conference on Liver Development, Metabolism, Disease and Cancer will be held in Suzhou, CHINA, located approximately 60 miles west of Shanghai. The conference will begin at 7:00pm on the evening of Monday, September 11, and will conclude after lunch, Friday, September 15, 2023.
The conference will include eight oral sessions and one poster session covering the latest findings across many topics in liver research from health to diseases, especially mechanistic dissections and immunotherapy of liver cancer. Many short talks will be selected from the openly submitted abstracts on the basis of scientific merit and relevance. Social events throughout the conference provide ample opportunity for informal interactions.
Major Topics:
1. Liver biology and cell lineage tracing
2. Liver progenitors and iPS cells
3. Liver metabolism and metabolic pathways
4. Alcoholic fatty liver diseases
5. Non-alcoholic fatty liver diseases and NASH
6. New technologies in liver research
7. Mechanisms of hepatocarcinogenesis
8. Immunotherapy of liver cancer
9. Translational and clinical liver studies
Keynote Speakers:
Steven Kliewer, UT Southwestern Medical Center
Invited Speakers:
Lei Dong, Nanjing University
Miguel Esteban, Guangzhou Institutes of Biomedicine and Health, CAS
Gen-Sheng Feng, University of California, San Diego
Bin Gao, National Institute on Alcohol Abuse Alcoholism, NIH
Daming Gao, Shanghai Institute of Biochemistry and Cell Biology
Valerie Gouon-Evans, Boston University
Mathias Heikenwälder, German Cancer Research Center (DKFZ)
Mitchell Ho, National Cancer Institute, NIH
Lijian Hui, Shanghai Institute of Biochemistry and Cell Biology, CAS
Junfang Ji, Zhejiang University
Klaus Kaestner, University of Pennsylvania
Jingya Li, Shanghai Institute of Materia Medica, CAS
Suthat Liangpunsakul, Indiana University School of Medicine
Jiandie Lin, University of Michigan
Wajahat Mehal, Yale School of Medicine
Eli Pikarsky, The Hebrew University of Jerusalem
Robert Schwartz, Cornell Medical Center, NYC
Li Tang, National Center for Protein Sciences, Beijing Institute of Lifeomics
Jan Tchorz, Novartis Institutes for BioMedical Research
Zhigang Tian, University of Science & Technology of China
Ludovic Vallier, Berlin Institute of Health
Cun Wang, Shanghai Cancer Institute, Shanghai Jiao Tong University
Hongyan Wang, Shanghai Institute of Biochemistry and Cell Biology
Cen Xie, Shanghai Institute of Materia Medica, CAS
Aimin Xu, The University of Hong Kong
Huaqiang Eric Xu, Shanghai Institute of Materia Medica, CAS
Bin Xue, Nanjing Medical University
Lars Zender, University Hospital Tübingen
Ning Zhang, Peking University
Zemin Zhang, Peking University
Dawang Zhou, Xiamen University
Shimei Zhuang, Sun Yat-sen Univeristy
We encourage abstracts to contain new and unpublished materials. The abstracts must be submitted electronically by the abstract submission deadline to be considered for selection. Selection of material for oral and poster presentation will be made by the meeting organizers. Status (fellow's talk/poster) of abstracts will be informed via email as soon as decisions have been made by the organizers.
Fellowship:
We are eager to have as many young people as possible attend since they are likely to benefit most from this meeting. A certain number of oral or poster presentations by graduate students and postdocs in this conference will be selected for fellowship (USD $100-$500) awards during the meeting. For more details, please visit Stipends
We look forward to seeing you at Suzhou in 2023.
Sponsored by:
